Control of sinus tachycardia as an additional therapy in patients with decompensated heart failure (CONSTATHE-DHF): A randomized, double-blind, placebo-controlled trial

J Heart Lung Transplant. 2016 Oct;35(10):1260-1264. doi: 10.1016/j.healun.2016.06.005. Epub 2016 Jun 7.

Authors

Marco Stephan Lofrano-Alves¹, Victor Sarli Issa¹, Bruno Biselli¹, Paulo Chizzola¹, Silvia Moreira Ayub-Ferreira¹, Edimar Alcides Bocchi¹

Affiliation

¹ Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.

PMID: 27469019
DOI: 10.1016/j.healun.2016.06.005

No abstract available

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Benzazepines / administration & dosage*
Cardiovascular Agents / administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Female
Follow-Up Studies
Heart Failure / complications*
Heart Failure / drug therapy
Heart Failure / physiopathology
Heart Rate / drug effects*
Heart Rate / physiology
Humans
Ivabradine
Male
Middle Aged
Tachycardia, Sinus / drug therapy*
Tachycardia, Sinus / etiology
Tachycardia, Sinus / physiopathology
Time Factors
Treatment Outcome

Substances

Benzazepines
Cardiovascular Agents
Ivabradine